Skip to content

Homoeopathic medicines for adults with Allergic Rhinitis

Role of Individualized Homoeopathic Medicine in the Management of Allergic Rhinitis Using Phatak Repertory - A Prospective Interventional Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106976
Enrollment
40
Registered
2026-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine selected using Phatak Repertory: Participants will be diagnosed for Allergic Rhinitis with the help of SFAR score and those fulfilling the inclusion

Sponsors

Dr. Anshu Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the diagnostic criteria of Allergic Rhinitis as per SFAR score Patients willing to give informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Patients suffering from any life-threatening illness and any other uncontrolled disease affecting quality of life or any other vital organ Patients suffering from any major complications and co-morbidities Pregnant women, lactating mothers, and women who are planning for pregnancy Patient on immunosuppressive therapy upto 6 months before start of study period

Design outcomes

Primary

MeasureTime frame
It is expected that individualized homoeopathic medicine selected using Phatak repertory has a significant effect in the management of Allergic rhinitis.Timepoint: Baseline to 6 months

Secondary

MeasureTime frame
The study will give group of homoeopathic medicines having role in the management of Allergic rhinitis. It is expected that there will be statistically significant changes in SFAR score at the end of the study. It is expected that there will be statistically significant changes in RQLQ questionnaire score at the end of the study. It is expected that there will be statistically significant changes in blood parameters viz. IgE , Eosinophil count, ESR at the end of the study.Timepoint: Baseline to 6 months

Countries

India

Contacts

Public ContactProf Dr Neetu Singh

Pt. Jawaharlal Nehru State Homoeopathic Medical College and Hospital

neetudoc@gmail.com7976301441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026